Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization

Submitted by Frida Mäkelä on Fri, 05/23/2025 - 10:49
  • Read more about Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization

Dissecting immune-mediated pathways in rheumatoid arthritis: A multivariate mediation analysis of antibodies and circulating proteins

Submitted by Frida Mäkelä on Fri, 05/23/2025 - 10:44
  • Read more about Dissecting immune-mediated pathways in rheumatoid arthritis: A multivariate mediation analysis of antibodies and circulating proteins

Genetic study of von Willebrand factor antigen levels ≤ 50 IU/dL identifies variants associated with increased risk of VWD and bleeding

Submitted by Frida Mäkelä on Fri, 05/23/2025 - 10:35
  • Read more about Genetic study of von Willebrand factor antigen levels ≤ 50 IU/dL identifies variants associated with increased risk of VWD and bleeding

Causal Inference of Different Smoke Exposure Statuses and Influenza Risk: Insights From a Mendelian Randomization Study

Submitted by Frida Mäkelä on Fri, 05/23/2025 - 10:30
  • Read more about Causal Inference of Different Smoke Exposure Statuses and Influenza Risk: Insights From a Mendelian Randomization Study

Targeted multi-layer analysis of PANoptosis-associated genes in the etiology of chronic kidney disease

Submitted by Frida Mäkelä on Fri, 05/23/2025 - 10:26
  • Read more about Targeted multi-layer analysis of PANoptosis-associated genes in the etiology of chronic kidney disease

Causal relationships between depression, anxiety, and myopia: a two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 05/21/2025 - 16:14
  • Read more about Causal relationships between depression, anxiety, and myopia: a two-sample Mendelian randomization study

Role of X chromosome and dosage-compensation mechanisms in complex trait genetics

Submitted by Frida Mäkelä on Wed, 05/21/2025 - 16:10
  • Read more about Role of X chromosome and dosage-compensation mechanisms in complex trait genetics

Causal links between plasma lipidome and ovarian cancer risk: evidence from Mendelian randomization

Submitted by Frida Mäkelä on Wed, 05/21/2025 - 15:44
  • Read more about Causal links between plasma lipidome and ovarian cancer risk: evidence from Mendelian randomization

Insights from bidirectional Mendelian randomization: Evaluating the influence of circulating inflammatory cytokines on prostatitis

Submitted by Frida Mäkelä on Wed, 05/21/2025 - 15:36
  • Read more about Insights from bidirectional Mendelian randomization: Evaluating the influence of circulating inflammatory cytokines on prostatitis

Multi-omics identify ribosome related causal genes methylation, splicing, and expression in prostate cancer

Submitted by Frida Mäkelä on Wed, 05/21/2025 - 15:26
  • Read more about Multi-omics identify ribosome related causal genes methylation, splicing, and expression in prostate cancer

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 133
  • Page 134
  • Page 135
  • Page 136
  • Current page 137
  • Page 138
  • Page 139
  • Page 140
  • Page 141
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement